This NDC is on FDA's drug shortage list (posted Jul 26, 2023)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
METHYLPHENIDATE ER 18 MG TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.6645 per EA under NDC 57664060688. Its NADAC has been published 257 times since Jan 20, 2021.
FDA first approved this application on Aug 19, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
18 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664060688
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205135FDA Approved
8/19/2020
TE Code
AB
On Market Since
8/20/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 18 MG TAB has been published 257 times since Jan 20, 2021, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6645 per EA |
|---|---|
| All-time high | $1.2966 (May 12, 2021) |
| All-time low | $0.5230 (Jul 20, 2022) |
| 52-week high | $0.7051 |
| 52-week low | $0.6645 |
| Median price | $0.7137 |
| Average price | $0.7561 |
| Largest weekly change | -44.5% (Sep 20, 2023) |
| Weeks tracked | 257 |
| Tracking since | Jan 20, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-5.8%
3Y
-32.1%
5Y
-35.3%
All
-23.4%
Last surveyed Dec 17, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 18 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 18 MG TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.6645 per EA (NDC 57664060688), effective Dec 17, 2025.
How has the price of METHYLPHENIDATE ER 18 MG TAB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 18 MG TAB has declined 23.4%. It has been tracked across 257 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 18 MG TAB?
Since Jan 20, 2021, the NADAC for METHYLPHENIDATE ER 18 MG TAB has ranged from a low of $0.5230 (Jul 20, 2022) to a high of $1.2966 (May 12, 2021), with a median of $0.7137 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 18 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 18 MG TAB, is $0.5758 per EA — about 13% below METHYLPHENIDATE ER 18 MG TAB.
Who manufactures METHYLPHENIDATE ER 18 MG TAB?
METHYLPHENIDATE ER 18 MG TAB (NDC 57664060688) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Is METHYLPHENIDATE ER 18 MG TAB in shortage?
Yes — NDC 57664060688 is currently listed in FDA's drug shortage database (posted Jul 26, 2023). Reported reason: Discontinuation of the manufacture of the drug.